![]() Method for preparation of quinoline carboxylic acid or theirs pharmaceutically acceptable salts
专利摘要:
The invention relates to a new process for the preparation of compounds of general formula (I), (wherein R stands for piperazinyl, 4-methyl-piperazinyl or 4-ethyl-piperazinyl group) and pharmaceutically acceptable salts thereof which comprises reacting a compound of general formula (II), (wherein R<1> and R<2> stand for halogen, for an aliphatic acyloxy group containing 2 to 6 carbon atoms and optionally substituted by halogen, or for an aromatic acyloxy group containing 7 to 11 carbon atoms) with a piperazine derivative of general formula (III), (wherein R<3> stands for hydrogen, methyl or ethyl) or a salt thereof and subjecting the compound of general formula (IV) thus obtained, (wherein R, R<1> and R<2> are as stated above) to hydrolysis after or without isolation and if desired converting the compound of general formula (I) thus obtained into a salt thereof or setting free the same from its salt. The compounds of general formula (I) are known antibacterial agents. The advantage of the present invention is that it makes the desired compounds of general formula (I) available in a simple manner, with high yields and in a short reaction time. 公开号:SU1701110A3 申请号:SU884613033 申请日:1988-12-07 公开日:1991-12-23 发明作者:Хермец Иштван;Керестури Геза;Вашвари Делле;Хорват Агнеш;Балог Мария;Ритли Петер 申请人:Хиноин, Дьедьсер Еш Ведьесети Термекек Дьяра Рт (Инопредприятие); IPC主号:
专利说明:
The invention relates to an improved method for producing quinoline carboxylic acids of the general formula Niya - increasing the yield of the target product and reducing the time of the process with its best selectivity. The synthesis is carried out by the reaction of the corresponding quinoline derivatives of the general formula where R2 and Pz are halogen, Cr-Sb is an alkyloxy group, with the corresponding piperazine derivative of the general formula R. (ttr-Cbr-MH-CHg, where Rt is CH3 or C2H5, at 90-110 ° C in a solvent, followed by by hydrolysis and isolation of the target product in the form of an acid or its salt, dimethyl sulfoxide is preferable as a solvent, and hydrolysis is carried out in an acidic (acetic acid) or alkaline (NaOH) medium. conditions allow you to increase process efficiency. 6 f-ri ly. in which R; - piperazinyl, 4-methylpiperazinyl or 4-ethylpiperazinyl groups, or their pharmaceutically acceptable salts, which have high antibacterial activity. A known method of producing quinolinecarboxylic acids by reaction 1-cyclopropyl-6-fluoro-7-chloro-4-oxo-1.4-dihydroquinoline-3-carboxylic acid and εν οιιιοζι of a cyclic amine in an organic solvent at 135 ~ 140 ° C. The purpose of the invention is to increase the yield of the target product, reducing the process time and increasing its selectivity. The goal is achieved by the interaction of the borate derivative of the formula (II) where R2 and R3 are halogen, an aliphatic acyloxy group containing from 2 to 6 carbon atoms with a piperazine derivative of the general formula r ^ nQnh where R4 is hydrogen, methyl or ethyl at 90 ° C, followed by hydrolysis with or without isolation the resulting compound of General formula (Iv) And where Ri, R2 and R3 have the indicated meanings with the release of the target product in the form of an acid or salt. In this case, dimethyl sulfoxide is mainly used as an organic solvent, the process is carried out in the presence of an acid-binding substance, such as an excess of the compound of the general formula III, the hydrolysis is carried out in an acidic or alkaline medium, using acetic acid as the acid, and sodium hydroxide as the alkaline agent , Example 1. The starting material can be obtained as follows. A mixture of 0.93 g of boric acid, 1.5 g of zinc chloride and 5.36 g of May 97, v / v,% propionic acid anhydride is stirred, and the temperature of the mixture is slowly increased. At 90 ° C, the suspension turns into a solution. Then, 3.1 g of ethyl 1-cyclopropyl-6-fluoro-7-chloro-1,4-di hydro-4-oxoquinoline-3-carboxylate was added to the mixture. The reaction mixture, which after a few minutes turns into a thick suspension, is cooled and given and diluted with 6 ml of water. The precipitated crystals are filtered, washed with methanol and dried. 4.18 g of [(1-cyclopropyl-6-fluoro-7-chloro-1,4-dihydro-4-oxoquinoline-3-carboxylate-0, 3 , 0 4 ) -dipropionate] boron are obtained, m.p. 181-182 ° C. Calculated,%: C 52.15; H 4.15; N 3.20. CwHieNOvBCIF Found,%; C 52.23; H 4.11; N, 3.31. In 16 ml of dimethyl sulfoxide, 4.1 g of 10 (1-cyclopropyl-6-fluoro-7-chloro-1,4-dihydro-4-oxoquinoline-3-carboxylate-0.0 jbis (acet- 0) -Bor and 2.8 g of piperazine anhydride to a brownish-red solution was added 40 ml of a 3% w / v -... 15 aqueous sodium hydroxide solution and the reaction mixture 1 was refluxed for 1 hour, Hot pale. the yellow solution was filtered and the pH was adjusted to 7 by adding 1.8 ml of 96% acetic acid 20. The reaction mixture was cooled to room temperature, white crystals precipitated the steels are filtered, washed with water and methanol and dried. The crude reaction product is purified by 25 boiling in 10 ml of water. 2.99 g are obtained 1-cyclop of the role of l-6-fluoro-7- (1-piperazinyl) 1,4-dihydro-4-oxoquinoline-3-carboxylic acid. The reaction product decomposes at 255 ° C. Calculated,%: C 61.62; H 5.48; N, 12.68. C17H18FN3O3 Found,%; C 61.58; H 5.50; N, 12.61. Example 2. By the interaction of (1-cyclopropyl-6-fluoro-4-chloro-1,4-dihydro-4 35-oxoquinoline-8-carboxylate-0 3 , 0 4 ) -bis (acetate-0) -6ora and N-methylpiperazine according to example 1 receive 1-cyclopropyl6-fluoro-7- (4-methylpiperazine) -1,4-dihydro4-oxoquinoline-3-carboxylic acid. The reaction product decomposes at 248-250 ° C. Example 3 In 16 ml of dimethylsulfoxide is heated to 90 ° C under stirring 4.1 g of (1-cyclopropyl-6-fluoro-7-chloro-1,4-dihydro-4-oxoquinoline -3-carboxylate 45-0 3 0 4 ) bis (acetate-0) -boron and 3.7 g of N-ethylpiperazine. After 10 minutes 40 ml of a 3% w / v aqueous solution of sodium hydroxide are added and the reaction mixture is refluxed for 50 hours. The hot solution is filtered and the pH is adjusted to 7 with 96% acetic acid. The reaction mixture is cooled, the precipitated crystals are filtered and washed with water. 55 3.3 g of 1-cyclopropyl-7- (4-ethylpiperazinyl) 6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid are obtained, mp 183-185 ° C. Calculated,%: C 63.35; H 6.17; N, 11.69. C19H22FN3O3 Found,%: C 63.31; H, 6.21; N, 11.70. Example 4. The starting material can be obtained as follows. May 50./vol.% Aqueous solution of 15 ml of hydrogen tetrafluoroborate (III) is reacted with 3.1 g of ethyl-1-cyclopropyl 5 pil-6-fluoro-7-chloro-1,4-dihydro-4-oxoquinol in-3-carboxylate for 2 hours at 80 ~ 90 ° C. After cooling, the precipitated crystals are collected by filtration, washed with 3 ml of methanol and dried. 10 3.22 g of [(1-cyclopropyl-6-fluoro-7-chloro-1,4-dihydro-4-oxoquinoline-3-carboxylate-0 3 .0 c-difluoro] boron are obtained, mp 283285 ° C. Calculated,%; C 47.39: H 2.45; N, 4.25. fifteen C13H8O3NBF3CI Found,%: C 47.54; H 2.40; N, 4.34. According to example 3, 3.3 g of [(1-cyclopropyl-6-fluoro-7-chloro-1,4-dihydro-4-oxoquinoline-3-carboxylate-03.04) difluoro] -boron 20 are reacted with 3, 7 g of Ethylpiperazine. 3.4 g of 1-cyclopropyl l-7- (4-ethylpiperazinyl) -6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid are obtained, which is mixed at any ratio with the product the reaction of example 3 does not cause melting temperature depression. Example 5. 2.0 g of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7- (1-piperazinyl) 30-quinoline-3-carboxylic acid was dissolved in 5 ml of 10% hydrochloric acid in phenolic medium, the reaction mixture is cooled to 0 ° C, and the precipitated crystals are filtered and dried in vacuum at 35 to 90 ° C. 1.9 g of salt are obtained: 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7 (1-piperazinyl) -quinoline-3-carboxylic acid hydrochloride as colorless crystals, 40 mp. 309-310 ° C. Example 6. 2.0 g of 1-cyclopropyl-6-fluoro p-1,4-di-guide po-4-o кСО-7- (1-pip e rasil yl) -quinoline-3-carboxylic acid is boiled in 3 ml of ethanol and 45 0.8 g of methanseric acid are added to the boiling mixture. After a few minutes, the precipitation of crystals begins. The mixture is cooled to 0 ° C, and the precipitated crystals are filtered, washed with ethanol and dried in vacuum at 90 ° C. Get 50 2.3 g of 1-cyclopropyl-6-fluoro-1,4-dihydro-4oxo-7- (1-piperazinyl) quinoline-3-carboxylic acid, m.p. above 300 ° C.
权利要求:
Claims (7) [1] Claim 1. The method of obtaining quinolinecarbonyl-55 output acids of the general formula 0N Λ (О where Ri is a liperazinyl. 4-methylpiperazinyl or 4-ethylpiperazinyl group, or their pharmaceutically acceptable salts, by the interaction of a quinoline derivative with a piperazine derivative when heated in an organic solvent, characterized in that. In order to increase the yield of the target product, reduce the process time and increasing its selectivity, a borate derivative of the formula where R2 and R3 is a halogen-aliphatic acyloxy group containing from 2 to 6 carbon atoms, which suspends they react with a piperazine derivative of the general formula R ^ N (IO where From is hydrogen, methyl or ethyl, at a temperature of 90-110 ° C, followed by hydrolysis after or without isolation of the obtained compound of the general formula where Ri, R2 and R3 have the indicated meanings, with the isolation of the target product as an acid or salt. [2] 2. The method of pop. 1, characterized in that dimethyl sulfoxide is used as an organic solvent. [3] 3. The method of pop. T, characterized in that the process is carried out in the presence of an acid binder such as an excess of a compound of general formula III. [4] 4. The method of pop. 1, characterized in that the hydrolysis is carried out in an acidic environment. [5] 5. The method of popp, 1 and 4, characterized in that acetic acid is used as the acid. [6] 6, The method according to p. 1. characterized in that the hydrolysis is carried out in an alkaline 5 medium. [7] 7. The method according to PP. 1 and 6, characterized in that sodium hydroxide is used as the alkaline agent in the hydrolysis. Priority by signs: 04/08/87 with Ri-piperazinyl, 4-methylpiperazinyl. 02/26/88 at Ri-piperazinyl, 4-methylpiperazinyl or 4-ethylpiperazinyl. Compiled by G. Zhukov Editor I. Derbak Tehred M. Morgenthal Corrector M. Maksimishinets Order 4480 Circulation Subscription VNIIIPI of the State Committee for Inventions and Discoveries at the State Committee for Science and Technology 113035, Moscow, Zh-35, Raushskaya nab ,, 4/5 ’ Production and Publishing Combine Patent, Uzhgorod, 101 Gagarin St.
类似技术:
公开号 | 公开日 | 专利标题 HUT58056A|1992-01-28|Process for producing quinolonecarboxylic acid derivatives SU1701110A3|1991-12-23|Method for preparation of quinoline carboxylic acid or theirs pharmaceutically acceptable salts RU1838302C|1993-08-30|Mixed anhydrides of quinolinecarboxylic acid and boric acid as intermediate products for synthesis of piperazinyl-3-quinolinecarboxylic acid derivatives showing antibacterial activity HU215429B|1999-04-28|Process for producing |-0 upper 3, 0 upper 4-bis|-borate and salts KR970005911B1|1997-04-22|Process for preparing quinoline carboxylic acid derivatives SU1722228A3|1992-03-23|Method for synthesis of quinoline carboxylic acid derivatives or its methane-sulphonate salt SU1604156A3|1990-10-30|Method of producing anhydrides of 1-ethyl-6-fluoro-7-chloro-4-oxo-1,4-dihydroquinoline-3-carbolic acid and boric acids KR970005910B1|1997-04-22|Process for the preparation of quinoline carboxylic acids EP0248876B1|1995-03-15|Process for the preparation of 1-methylamino-quinoline-carboxylic acid derivatives US5294712A|1994-03-15|Process for the preparation of quinoline carboxylic acids RU2049783C1|1995-12-10|Method of synthesis of quinoline carboxylic acid derivatives or their pharmaceutically acceptable salts US5380845A|1995-01-10|Process for the preparation of quinoline carboxylic acid derivatives RU2044734C1|1995-09-27|Method of synthesis of quinoline carboxylic acid or its pharmaceutically acceptable salts and compounds US5284950A|1994-02-08|Process for the preparation of quinoline carboxyolic acids WO1990006922A1|1990-06-28|Process for the preparation of quinoline carboxylic acid derivatives HU198728B|1989-11-28|Process for producing quinolinecarboxylic acid derivatives CZ97496A3|1996-10-16|Process for preparing 1-cyclopropyl-6-fluoro-1, 4-dihydro-7-£|-5-methyl-2,5-diazabicyclo £2.2.1|hept-2-yl|-4-oxo-3-quinolinecarboxylic acid and salts thereof SI9300192A|1994-12-31|Process for preparation of 1-subs.-6-fluoro-4-okso-7-|-1,4-dihydroquinolin-3-carboxylic acid, novel intermediate and process for thereof
同族专利:
公开号 | 公开日 DE3854109T2|1995-11-30| JP2693987B2|1997-12-24| CS242088A2|1990-09-12| DK175037B1|2004-05-10| DK682288D0|1988-12-07| DD269848A5|1989-07-12| CN88101907A|1988-10-26| HUT46686A|1988-11-28| AT124687T|1995-07-15| CN1025616C|1994-08-10| US5300644A|1994-04-05| AU1572188A|1988-11-04| AU612648B2|1991-07-18| HU198709B|1989-11-28| JPH01503301A|1989-11-09| DK682288A|1988-12-07| US5091530A|1992-02-25| EP0309537B1|1995-07-05| CS274460B2|1991-04-11| EP0309537A1|1989-04-05| WO1988007993A1|1988-10-20| DE3854109D1|1995-08-10|
引用文献:
公开号 | 申请日 | 公开日 | 申请人 | 专利标题 DE3033157A1|1980-09-03|1982-04-01|Bayer Ag, 5090 Leverkusen|7-AMINO-1-CYCLOPROPYL-4-OXO-1,4-DIHYDRO-NAPHTHYRIDINE-3-CARBONIC ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THE ANTIBACTERIAL AGENTS CONTAINING THEM| US4670444B1|1980-09-03|1999-02-09|Bayer Ag|and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds| DE3142854A1|1981-10-29|1983-05-11|Bayer Ag, 5090 Leverkusen|1-CYCLOPROPYL-6-FLUOR-1,4-DIHYDRO-4-OXO-7-PIPERAZINO-CHINOLINE-3-CARBONIC ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THEIR CONTAINING ANTIBACTERIAL AGENTS| JPS5980683A|1982-10-30|1984-05-10|Koei Chem Co Ltd|6-fluoro-1,8-naphthyridine derivative and its preparation| JPH0240066B2|1982-12-27|1990-09-10|Daiichi Seiyaku Co| JPH0475239B2|1983-10-03|1992-11-30| JPH0372073B2|1983-10-07|1991-11-15|Daiichi Seiyaku Co| JPH0372230B2|1983-12-13|1991-11-18|Daiichi Seiyaku Co| HU196415B|1985-12-09|1988-11-28|Chinoin Gyogyszer Es Vegyeszet|Process for preparing quinoline carboxylic acid boric acid anhydrides| HU196782B|1985-12-09|1989-01-30|Chinoin Gyogyszer Es Vegyeszet|Process for production of quinoline carbonic acid| HU196218B|1985-12-09|1988-10-28|Chinoin Gyogyszer Es Vegyeszet|Process for preparing quinoline carboxylic acid boric acid anhydrides| US4940710A|1986-01-17|1990-07-10|American Cyanamid Company|7-piperazinyl-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids| SI8810667A8|1987-04-08|1996-04-30|Chinoin Gyogyszer Es Vegyeszet|Anhydride of quinoline carboxylic acid of boron acid and process for their production.| HU198709B|1987-04-08|1989-11-28|Chinoin Gyogyszer Es Vegyeszet|Process for producing quinoline-carboxylic acid derivatives| JP2693988B2|1987-06-24|1997-12-24|キノインギオギスゼルエスベギエスゼチテルメケクギヤラアールティー.|Method for producing quinoline carboxylic acid derivative| JPS6419069A|1987-07-14|1989-01-23|Dainippon Pharmaceutical Co|Production of polyhalogenoquinoline derivative|HU198709B|1987-04-08|1989-11-28|Chinoin Gyogyszer Es Vegyeszet|Process for producing quinoline-carboxylic acid derivatives| HU203746B|1988-12-22|1991-09-30|Chinoin Gyogyszer Es Vegyeszet|Process for producing quinoline-carboxylic acid derivatives| JPH0778065B2|1990-07-06|1995-08-23|杏林製薬株式会社| bisBoron compound, salt thereof, and method for producing the same| GB9118183D0|1991-08-23|1991-10-09|Solanki Kishor K|Imaging of infections| US5440061A|1994-03-29|1995-08-08|The Procter & Gamble Company|Hydrolysis of methyl esters in dimethylsulfoxide for production of fatty acids| NZ260530A|1994-05-16|1997-06-24|Nigel Paul Maynard|Organoborate complexes of divalent metal; use as timber treament agents| ES2092963B1|1995-04-12|1997-12-16|Sint Quimica Sa|PROCEDURE FOR THE PREPARATION OF ACID 1-CICLOPROPIL-6-FLUORO-1, 4-DIHIDRO-7--5-METHYL-2,5-DIAZABICICLOHEPT-2-IL) -4 -OXO-3-QUINOLINCARBOXILICO AND ITS SALTS.| ES2095809B1|1995-07-27|1997-12-16|Sint Quimica Sa|PROCEDURE FOR THE PREPARATION OF NAFTIRIDIN CARBOXYLIC ACIDS AND THEIR SALTS.| CN101195614B|2006-12-04|2011-10-26|河南康泰制药集团公司|Production of balofloxacin and purification process thereof| CN101671302B|2008-12-30|2011-03-30|广东海康兽药有限公司|Production process of enrofloxacin antibacterial drug for fowl and livestock|
法律状态:
优先权:
[返回顶部]
申请号 | 申请日 | 专利标题 HU871505A|HU198709B|1987-04-08|1987-04-08|Process for producing quinoline-carboxylic acid derivatives|MD94-0132A| MD72C2|1987-04-08|1988-04-08|The method of obtaining chinolyncar borxylic acids or its salts which can be used in pharmaceutics| LV930486A| LV5252A3|1987-04-08|1993-06-08|Saturation of quinolink carbohydrates or their pharmacologically acceptable bonds| LTRP647A| LT2190B|1987-04-08|1993-06-12|THE PRICE OF CHINOLINKARBONAR RUGCIE OR PHARMACEUTICAL ACCEPTABLE SALT| 相关专利
Sulfonates, polymers, resist compositions and patterning process
Washing machine
Washing machine
Device for fixture finishing and tension adjusting of membrane
Structure for Equipping Band in a Plane Cathode Ray Tube
Process for preparation of 7 alpha-carboxyl 9, 11-epoxy steroids and intermediates useful therein an
国家/地区
|